reviewNature Reviews Drug DiscoveryNov 30, 2012Closed access

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

AstraZeneca (United Kingdom) · GlaxoSmithKline (United Kingdom) · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

740
total citations
FWCI
20.39
Percentile
100%
References
105
Citations per year

Authors

7

Topics & keywords

Keywords
  • Profiling (computer programming)
  • Drug discovery
  • Drug
  • Medicine
  • Pharmaceutical industry
  • Drug development
  • New drug application
  • Pharmacology
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.